Category: News This Week

  • Howard Willard Steps Down

    Howard Willard Steps Down

    Altria sign

    Altria CEO Howard Willard has stepped down after nearly 30 years with the company. He is currently recovering from Covid-19.

    Billy Gifford, chief financial officer, will assume the CEO position permanently. Gifford was standing in as interim CEO while Willard was out on medical leave.

    Altria is separating the roles of CEO and chairman; Thomas Farrell, the board’s former independent presiding director, has been appointed chairman.

    Salvatore Mancuso, Altria’s finance and procurement vice president, has been appointed as chief financial officer to replace Gifford.

  • CTFK Wants Vape Shops Labeled as Non-Essential

    CTFK Wants Vape Shops Labeled as Non-Essential

    Chakrapong Worathat | Dreamstime.com

    The Campaign for Tobacco-Free Kids (CTFK) is sending out email blasts urging for a “Call to Action” to pressure U.S. President Donald Trump to label vape shops as non-essential businesses.

    “In a new low, vape shops are lobbying the Trump Administration to be declared “essential businesses” so they can stay open during the COVID-19 crisis. This is ludicrous and we need your help to stop it,” the email begins. “It is the height of disgrace for the vaping industry to argue that e-cigarettes, which damage the lungs, should be considered essential during a lung disease pandemic. It has never been more urgent for us to protect our kids and their health, not vape shops.”

    Some states have labeled vape shops as non-essential businesses. In states such as Ohio, vapor advocacy groups such as the Ohio Vapor Technology Association (OHVTA) have asked its members to close their doors during the pandemic. Ohio, however, allows online sales. Many US states do not.

    Gas stations and convenience stores, where the majority of combustible cigarettes are purchased, are labeled essential businesses. CTFK does not make any mention of asking for businesses that sell deadly cigarettes to be closed.

  • Trump Halts WHO Funding

    Trump Halts WHO Funding

    U.S. President Donald Trump announced that he is halting funding to the World Health Organization (WHO) during its fight against the coronavirus outbreak.

    World leaders condemned this decision.

    “It is my belief that the World Health Organization must be supported as it is absolutely critical to the world’s efforts to win the war against Covid-19,” said Antonio Guterres, secretary general of the United Nations.

    “Blaming does not help,” Heiko Maas, the German foreign minister, wrote on Twitter. “The virus knows no borders.”

    Trump accused the WHO of “severely mismanaging and covering up” the coronavirus outbreak and said the U.S. will withhold funding until it can review the organization’s actions.

    The U.S. is the WHO’s biggest donor, and halting funding will deprive the organization of about 10 percent of its budget during the crisis.

  • Colorado Temporarily Legalizes Online Marijuana Sales

    Colorado Temporarily Legalizes Online Marijuana Sales

    Bowl of cannabis

    Colorado has made the online sale of recreational marijuana legal during the coronavirus outbreak.

    Marijuana can be purchased online and picked up at the dispensary under the executive order that went into effect on March 20. Delivery is not allowed under the order, however.

    Massachusetts, Michigan, Illinois and Oregon also allow for the online purchase of recreational marijuana, but the practice is limited because while marijuana is still federally illegal, many credit card companies will not process the purchases.

    In some states, marijuana dispensaries are listed as essential businesses and are allowed to stay open during stay-at-home orders.

    Some believe that deliveries should also be allowed during the coronavirus crisis. “We need to be able to have as little contact as possible to people,” said Ben Prater, manager of Cannabis Station by Rocky Mountain High in Denver. “If people are sick or if they’re immunocompromised, they don’t need to be leaving their house during this time. So, I think that delivery is just kind of a necessity at this point.”

    The online sale of marijuana will be prohibited again once the executive order expires. Colorado emergency rules can only stay in effect for 120 days.

  • FDA Extends Comment Period  for Information on EVALI

    FDA Extends Comment Period for Information on EVALI

    Edgars Sermulis – Dreamstime.com

    In response to requests from the public, FDA is extending the comment period for a request for information (RFI) seeking data and information related to the use of vaping products that are associated with lung injuries

    The RFI, initially published in the Federal Register on Feb. 18, responds to direction from Congress to gather additional information that could help identify and evaluate additional steps that could be taken by the agency to “address the recent pulmonary illnesses reported to be associated with the use of e-cigarettes and vaping products.”

  • RELX Sends Relief Supplies to Customers

    RELX Sends Relief Supplies to Customers

    Courtesy: RELX

    RELX Technology announced the extension of the RELX “For You With Care” project to support its international partners during the COVID-19 crisis. RELX will initially send 78,200 masks and over 515 gallons of hand sanitizer to its global distributors, partners and store owners.

    The supplies will be sent to countries in Asia, Europe, Canada and South America. RELX will continue to follow the developments of COVID-19 globally and will send essential supplies to its partners and employees that are in need.

    “RELX is wholly committed to supporting the well-being of our employees, partners, and store owners during the COVID-19 pandemic. As a global startup, we are doing what we can to help our global community. We hope our modest donation will help them during these trying times,” said RELX founder and CEO Kate Wang.

    In late January, RELX kicked off the RELX For You With Care Project by donating RMB 1 million to the Institute of Psychology, China Academy of Science through the Shanghai Soong Ching Ling Foundation to support a training program designed to provide mental health support services.

    Courtesy: RELX
  • Opinion: Four-Month FDA Extension Not Sufficient

    Opinion: Four-Month FDA Extension Not Sufficient

    Doctor is comparing electronic vaporizer and conventional tobacc
    Photo: Vchalup | Dreamstime.com

    Consumers are staying home and spending less as COVID-19 and social distancing mandates sweep across the globe. The extreme, necessary steps to control the spread of the virus have already taken an economic toll, and there certainly will be a long-term impact on individual businesses and workers. One industry, in particular, will likely fail without swift federal action: e-cigarettes, according to Michelle Minton with the Competitive Enterprise Institute.

    Cigarettes may prove “pandemic-proof.” Since they are often sold at outlets deemed “essential” under the current lockdown, cigarettes continue to be available and big tobacco companies have so far remained financially unscathed. But the same is not true for their lower-risk competitors. Vape shops, which sell vapor products, like e-cigarettes, have not been universally recognized as essential businesses, so they have been forced to close.

    To maximize ways to fight the virus, many states have pressed pause on certain rules and regulations (leading many to wonder if they were #NeverNeeded in the first place.) For example, Vermont Governor Phil Scott signed an order lifting the state ban on home alcohol delivery. This was a pragmatic move, as Reason’s Guy Bentley aptly put it. Vermont lawmakers understand that people still want to imbibe, and at-home delivery discourages unnecessary booze runs.

    Yet that pragmatism hasn’t been extended to e-cigarettes, and Governor Scott’s online e-cigarette sales ban enacted last year remains in place. As a result, some adults now find themselves cut off from the products they rely on to stay smoke-free. Without swift federal action, they may be cut off permanently as vape shops go belly up, and many people will revert to smoking.

    The last year has already been difficult for those who sell and enjoy vapor products. Even as the evidence that e-cigarettes are relatively harmless for adults and highly effective for smoking cessation has become clearer, calls to ban or restrict e-cigarettes have only grown louder. Groups that oppose nicotine use, no matter how safe, ramped up attacks, spending millions to promote the idea that e-cigarettes are no different than cigarettes and to foment panic over the non-existent “epidemic” of youth vaping.

    Last summer, as scores of mostly young people fell ill with a mysterious lung ailment, anti-tobacco groups (with the aid of the CDC and news media) convinced people e-cigarettes were to blame, obfuscating the fact that the injuries were caused by black market THC vaping products, contaminated with vitamin E acetate (an oil that cannot be mixed into nicotine-containing e-cigarettes).

    By exploiting fear and confusion, e-cigarette opponents amassed support among the public and lawmakers for restrictions on e-cigarettes. Cities and states instituted onerous new rules, including banning all e-cigarette sales (but not traditional cigarettes), prohibiting flavored e-cigarettes, restricting sales to in-person transactions, and criminalizing possession of certain e-cigarettes.

    Some members of Congress tried to make these rules national, holding several hearings antagonistic toward vaping and considering a number of bills. Rep. Frank Pallone’s (D-NJ) bill, which bans all flavors except “tobacco,” prohibits online and mail-order sales and raises the national tobacco purchasing age limit to 21 (which it already is), passed the House. If enacted, it would make e-cigarettes less attractive, harder to get, and more expensive—leading some to label the bill a “win for cigarettes.”

    E-cigarette supporters battled threats to products they believe saved their lives. But unless federal regulators take immediate action there will be no industry left to save: By May 12, 2020 all vapor products must either submit a pre-market tobacco application (PMTA) to the Food and Drug Administration (FDA) for approval or exit the market. Filing a PMTA is an expensive and time-consuming task, which the FDA admitted would Eliminate 99 percent of the e-cigarette market. COVID-19 disruption could make that figure nearer to 100 percent.

    Last week, the FDA submitted a request to delay the PMTA deadline by four months, but even if granted, this would merely push the inevitable end of the e-cigarette industry to September 2020. The FDA should go further: Make the process, which vapor industry experts estimate takes over 1,700 hours and millions of dollars, quicker and cheaper for small companies. Although Health and Human Services Secretary Alex Azar announced plans in January to create a “streamlined” avenue for small businesses, that has yet to materialize.

    In the meantime, anti-nicotine advocates are still trying to spread misinformation, slip state-wide vaping bans around the normal legislative process, and, ludicrously, link COVID-19 deaths to e-cigarette use—for which there is zero evidence. Worse, some have even encouraged countries to reject critically needed medical equipment like ventilators if donated by Big Tobacco.

    The outbreak of COVID-19 should elevate the value of harm reduction—the idea that you can’t entirely stop people from engaging in risky behavior, but you can reduce harm by encouraging them to do so in the least risky way possible. E-cigarettes are the best way we know so far to reduce the harms related to nicotine use. They are vastly safer than smoking and more popular than most other forms of tobacco cessation. Lawmakers should do everything in their power to keep e-cigarettes a viable option for smoking cessation.

  • Avail Gives More Than 5,000 Masks to Caregivers

    Avail Gives More Than 5,000 Masks to Caregivers

    James Xu

    Avail Vapor has donated more than 5,000 masks to the Virginia Department of Emergency Management to help medical professionals on the front lines of the coronavirus battle protect themselves.

    The idea came to light a few months ago when Avail employees heard about the shortage of masks in China when Covid-19 initially struck. Avail works closely with many Chinese suppliers, and Avail employees wanted to support these suppliers in their time of need.

    Employees from around the U.S. gathered masks to donate; as a result, Avail shipped thousands of masks to its overseas partners. Now that the United States is experiencing a shortage in masks, those same Chinese colleagues have returned the generosity and shipped thousands of masks to Avail headquarters for employees and health care workers.

    “To be successful, our business has always been highly collaborative with global partners,” said James Xu, CEO and chairman of Avail, and a Chinese American. “To see our employees proactively answer a need for their Chinese counterparts was special. Now we are so grateful to our Chinese friends for helping us defend our citizens in this pandemic.”

    In addition, Avail has implemented new programs to help its customers during this unprecedented time. Since March 18, 2020, Avail customers who are burdened with a financial impact from Covid-19, as well as those in the medical community or who are first responders, have been eligible for a one-time purchase of select e-liquids for a penny ($0.01 transactional fee plus applicable taxes). Avail is also offering call-ahead and curbside pickup at all retail locations, as the health, safety and well-being of its staff and customers is paramount.

    Avail employs more than 350 people across the U.S. The company has committed to compensate staff for work time lost due to Covid-19 or influenza. In addition, if employees need further financial assistance, they can apply through the Xu Fund, a special employee assistance fund dedicated to supporting Avail staff in the event of personal and family hardships. CEO and Chairman Xu donates 100 percent of his salary to support the fund. Since 2018, the Xu Fund has helped 90 Avail employees.

  • Figr Introduced in British Columbia

    Figr Introduced in British Columbia

    Pyxus International’s wholly owned indirect subsidiary Figr Brands has introduced its legal recreational cannabis products into British Columbia, Canada, marking Figr’s first western provincial entry in its planned expansion across the country.

    Figr’s cannabis products, including the brand’s two newest strains, are now available for purchase through BC Cannabis.

    “Figr’s entrance into British Columbia is an exciting step for Figr as the company continues to expand across Canada,” said Pieter Sikkel, Pyxus president and CEO. “We are proud of Figr’s dedication and commitment to providing Canadians new and continued access to high-quality, fully traceable cannabis products, particularly as Canada navigates the unprecedented challenges of the Covid-19 crisis. Cannabis is considered an essential business in British Columbia, and Figr is committed to meeting the demand of consumers while protecting the health and well-being of its employees.”

    Within the last nine months, Figr has expanded into three new markets across Canada as well as introduced its initial suite of Figr 2.0 products. Figr’s products are now available in five Canadian provinces through retail locations and online stores, including Prince Edward Island, Nova Scotia, New Brunswick, Ontario and British Columbia.

    All of Figr’s cannabis products are tracked from seed-to-sale by SENTRI, Pyxus’ proprietary track-and-trace platform.

  • Study: States With Legal THC had Fewer EVALI Cases

    Study: States With Legal THC had Fewer EVALI Cases

    cannabis vape
    photo: Jeremynathan | Dreamstime

    States with laws legalizing recreational marijuana had fewer cases of e-cigarette/vaping-related lung injury (EVALI) than states without such policies in 2019, researchers reported.

    In states that had legalized recreational marijuana, the EVALI case rate averaged 1.7 per million population (95% CI 0.3-3.1), far lower than states where it’s legal only for medical purposes (8.8 per million, 95% CI 5.1-12.5) or completely illegal (8.1 per million, 95% CI 4.1-12.0), reported Alex Hollingsworth, PhD, of Indiana University in Bloomington, and colleagues, according to an article on medpagetoday.com.

    Moreover, the number of cases was significantly lower in states with legal recreational marijuana compared to those where it was not after adjusting for vaping rates (difference 7.2 cases per million, 95% CI -11.8 to -2.6, P=0.003), they wrote in a JAMA Network Open research letter, according to the story.

    “It appears states that have legal access to marijuana have lower rates of EVALI cases, which is consistent with the hypothesis that people have demand for marijuana products, and in states where they don’t have access to them in this regulatory fashion, they end up purchasing them elsewhere,” Hollingsworth told MedPage Today.